Medical community finds ways to make TAVR safer for at-risk patients
Posição atual:
> This Story

Início de uma sessão ou Registo to rate this News Story
Forward Printable StoryPrint Comment




More Magazine Features

A look back at the remarkable career of Ed Sloan Sr. Celebrating the life and career of the original parts vendor

The value of ISOs in an era of personalization and consolidation The unique value proposition of high quality third-party service

What to look for in an OEM service contract Communication the unique needs of your facility is key to getting the right coverage

The road ahead for breast density awareness It's been a good year for advocacy, here's what happens next

OB/GYN ultrasound: is the field ready to adopt new technology in the market? What do new capabilities mean for creatures of habit?

See All Magazine Features  

Cardiology Homepage

New 3D bioprinting method can create organs from collagen Major structural protein in the human body

New AI solution identifies high-risk patients from chest X-rays MGH tool may help detect heart disease, lung cancer

Key success criteria for the creation of an outpatient heart failure clinic Deb Thompson, senior consulting manager for Cardiology at Philips discusses what is required for the efficient management of a multi-disciplinary heart care team

Cardiology occupies a unique space in medical informatics Looking at enterprise imaging and informatics through the lens of cardiology at SIIM

MiE showcases cardiac PET scanner, Ancoris, at SNMMI Provides simultaneous 3D cardiac PET perfusion and CFR

AI tool for Alexa and smart devices detects cardiac arrest in sleeping patients Monitors patients for agonal breathing

Mount Sinai surgeons first in NY to perform minimally-invasive heart bypass surgery Only for highly-skilled surgeons for now

New dye helps control 'lighting' for sharper images of heart May help identify early signs of heart disease

Evaluating the cost-effectiveness of AEDs in the U.S. Insights from Dr. Lars W. Andersen on research he conducted and what it should mean for the future of public defibrillators

The 2019 Heart Rhythm Society scientific sessions: advanced technology in electrophysiology Four key takeaways

The BASILICA technique caters to
patients who are at risk of coronary
artery obstruction.

Medical community finds ways to make TAVR safer for at-risk patients

por Lauren Dubinsky , Senior Reporter
From the April 2019 issue of DOTmed HealthCare Business News magazine

Experts agree that transcatheter aortic valve replacement (TAVR) is a revolutionary and lifesaving treatment option for severe symptomatic aortic stenosis.

Dr. Jaffar M. Khan of the National, Heart, Lung, and Blood Institute (NHLBI), which is part of the National Institute of Health (NIH), referred to TAVR as “one of the greatest achievements in interventional medicine in our lifetime,” but readily acknowledges that it is not safe for every patient.

Story Continues Below Advertisement

Servicing GE/Siemens Nuclear Medicine equipment with OEM trained engineers

Numed, a well established company in business since 1975 provides a wide range of service options including time & material service, PM only contracts, full service contracts, labor only contracts & system relocation. Call 800 96 Numed for more info.

Dr. Jaffar M. Khan
Patients who are at risk of coronary artery obstruction, for example, face a 50 percent chance of dying if they undergo the treatment. According to Khan, 100,000 TAVR procedures were performed last year in the U.S. and about 1 percent of those were at risk of or went on to develop coronary artery obstruction.

In order to make this procedure safer for that subset of patients, Khan and his team at the NHLBI developed a technique called Bioprosthetic Aortic Scallop Intentional Laceration to prevent latrogenic Coronary Artery obstruction (BASILICA).

This technique involves the interventional cardiologist weaving an electrified wire through a catheter and using it to cut the patient’s leaflet in two. Splitting the leaflet in half ensures that it cannot block the coronary artery when it is pushed aside by the transcatheter heart valve.

In a recent study, the team tested the BASILICA technique on seven severely ill patients who qualified for “compassionate use” since there was no other treatment option available for them. All of the patients had a successful TAVR procedure and did not experience coronary artery obstruction, stroke or any other major complication.

In addition, they were doing well when they reached the 30-day-mark after the procedure. Starting in January, the team began enrolling patients in a multicenter early feasibility study, which is sponsored by the NHLBI, to evaluate BASILICA.

This technique was a result of collaboration between NHLBI and colleagues at the University of Washington in Seattle, Henry Ford Hospital in Detroit and Emory University Hospital in Atlanta.

“Since the first procedure in June 2017, there have been over 150 BASILICA procedures performed across North America and Europe,” said Khan. “Operators are eager to learn the technique to offer this to patients who have no other options.”
  Pages: 1 - 2 - 3 - 4 - ... >>

Cardiology Homepage

You Must Be Logged In To Post A Comment